News &
Media

Neurotech International (NTI) has secured an option to acquire an exclusive worldwide licence to use cannabis strains from Dolce Cann Global.

The proprietary cannabis strains will be medicinally used to treat neurological disorders such as autism, epilepsy and ADHD.